BioPharmX News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

25.06.19	BioPharmX: Phase 2b Trial Of BPX-04 Meets Primary, Secondary Endpoints (RTTNews)
15.03.19	ATOS Skyrockets, BPMX Gets "Going Concern" Warning, Respite For KPTI (RTTNews)
20.06.18	Cetera Financial Group Launches 401(k) Practice Development Program in Demonstration of Long-Term Commitment to Supporting Retirement Plan-Focused Advisors (PR Newswire)
19.06.18	New Patient-Centered Panel Helps BioPharmX Define its Role in the Future of Dermatology (PR Newswire)
07.06.18	BioPharmX Reports First Quarter 2019 Financial Results (PR Newswire)
24.05.18	BioPharmX Studies Show Hydrophilic Topical Minocycline Gels May Be the Preferred Treatment Option for Acne, Rosacea Patients (PR Newswire)
26.04.18	BioPharmX Reports Fourth Quarter and Full Year 2018 Financial Results (PR Newswire)
21.03.18	BioPharmX Cancels Presentation at Oppenheimer's 28th Annual Healthcare Conference Due to Severe Weather (PR Newswire)
20.03.18	U.S. Patent and Trademark Office Awards BioPharmX Patent Protection for Novel Tetracycline-class Topical Drug Compositions (PR Newswire)
14.03.18	BioPharmX to Present at Oppenheimer's 28th Annual Healthcare Conference (PR Newswire)
05.03.18	BioPharmX to Present at 30th Annual ROTH Conference (PR Newswire)
05.02.18	Simpson Manufacturing Co., Inc. Announces 2017 Fourth Quarter and Full-Year Financial Results (PR Newswire)
26.01.18	BioPharmX To Present Data On New Fluorescence Lifetime Imaging Microscopy to Measure How Effectively Topically Applied Minocycline Reaches Targets in Skin (PR Newswire)
12.01.18	BioPharmX To Present BPX-04 Rosacea Data At Two Leading Clinical Conferences This Month (PR Newswire)
07.12.17	BioPharmX Reports Third Quarter 2018 Financial Results (PR Newswire)
04.12.17	BioPharmX Demonstrates Topical Minocycline Gel May Exhibit Relevant Antimicrobial and Anti-inflammatory Properties for the Treatment of Acne at ASCB 2017 (PR Newswire)
08.11.17	BioPharmX Receives Concurrence from FDA on Phase 3 Acne Study Plans (PR Newswire)
18.10.17	BioPharmX to Present at Re-entering Antibacterial Discovery and Development Summit 2017 (PR Newswire)
18.10.17	SunPower To Supply 291 Megawatts in Second Round CRE4 French Tenders for Solar Projects (PR Newswire)
11.10.17	BioPharmX Collaborates with Wellman Center for Photomedicine to Develop Pioneering, Cost-Effective Technique to Visualize Drug Delivery (PR Newswire)
13.09.17	BioPharmX Reports Second Quarter 2018 Financial Results (PR Newswire)
13.09.17	SmartKids, the 'Netflix' of learning apps (PR Newswire)
12.09.17	BioPharmX Announces Preliminary Data from Rosacea Feasibility Study (PR Newswire)
05.09.17	BioPharmX to Present at Rodman & Renshaw 19th Annual Global Investment Conference (PR Newswire)
10.08.17	Microsoft announces the Coco Framework to improve performance, confidentiality and governance characteristics of enterprise blockchain networks (PR Newswire)
27.07.17	Summer AAD Panel to Discuss BPX-01 for Acne and Rosacea (PR Newswire)
25.07.17	Stock Performance Review on Biotech Industry -- BioPharmX, AmpliPhi Biosciences, Actinium Pharma, and Matinas BioPharma (PR Newswire)
13.07.17	BioPharmX To Present Phase 2b Clinical Trial Data at National DEF Essential Resource Meeting 2017 (PR Newswire)
22.06.17	BioPharmX to Present Phase 2b Clinical Trial Acne Data at Alabama Dermatology Society Summer Symposium (PR Newswire)
14.06.17	BioPharmX Invited to Present at World Preclinical Congress (PR Newswire)
13.06.17	BioPharmX Reports First Quarter 2018 Financial Results (PR Newswire)
23.05.17	Increasing Flurry of FDA Orphan Drug Development Activity Fueling Uptick of Enthusiasm for Few Pharma Stocks (PR Newswire)
23.05.17	Increasing Flurry of FDA Orphan Drug Development Activity Fueling Uptick of Enthusiasm for Few Pharma Stocks (PR Newswire)
03.05.17	BioPharmX Reports Positive Topline Results of BPX-01 Topical Minocycline for Acne (PR Newswire)
28.04.17	BioPharmX Announces Closing of $5.0 Million Offering (PR Newswire)
26.04.17	BioPharmX Announces $5.0 Million Offering (PR Newswire)
20.04.17	BioPharmX Completes Last Subject Visit in its Phase 2b Trial of BPX-01, Expects to Report Topline Results First Half of May 2017 (PR Newswire)
30.03.17	BioPharmX AACR Poster Will Present Findings Suggesting Molecular Iodine Inhibits Breast Cancer Cell Growth and Drives Cancer Cell Death (PR Newswire)
23.03.17	BioPharmX Reports Fourth Quarter and Full Year 2017 Financial Results (PR Newswire)
21.03.17	BioPharmX Invited to Present at 27th Annual Oppenheimer Healthcare Conference (PR Newswire)
16.03.17	BioPharmX to Report Fourth Quarter and Full Year Financial Results (PR Newswire)
13.03.17	BioPharmX Society of Toxicology Poster Suggests Promise of BPX-01 as Topical Acne Therapy, Highlights Safety (PR Newswire)
02.03.17	BioPharmX Presents Poster at American Academy of Dermatology Annual Meeting Suggesting BPX-01 Safely, Efficiently Delivers Acne-Fighting Minocycline to Pilosebaceous Units (PR Newswire)
26.01.17	SPIE Photonics West Presentations to Show BioPharmX was First to Visualize Minocycline on the Skin Using Multiphoton Microscopy (PR Newswire)
23.01.17	Specialty Pharma Industry Veteran Charles Gregory Vontz Joins BioPharmX Board of Directors (PR Newswire)
12.01.17	BioPharmX Data Suggest Anti-Inflammatory Activity of BPX-01 Topical Minocycline Gel (PR Newswire)
04.01.17	BioPharmX Completes Enrollment of BPX-01 Phase 2b OPAL Clinical Trial for Acne Vulgaris (PR Newswire)
13.12.16	BioPharmX Corporation Reports Third Quarter Financial Results (PR Newswire)
06.12.16	BioPharmX to Report Third Quarter Financial Results (PR Newswire)
05.12.16	BioPharmX Presents Research at Cell Biology 2016 Showing How Molecular Iodine Promotes Breast Health by Attacking Fibrocystic Breast Tissue (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Lonza Grp	587.40	0.93 %	K V
Novartis	95.64	0.06 %	K V
Swiss Re	139.05	-0.25 %	K V
Nestle	77.28	-0.26 %	K V
Roche Hldg G	284.90	-0.38 %	K V
ABB	48.74	-2.42 %	K V
Sika	226.60	-2.87 %	K V
UBS Group	31.40	-2.91 %	K V
Logitech Intl	88.40	-3.37 %	K V
Kuehne+Nagel Int	200.10	-3.61 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu BioPharmX Corp

Aktien Top/Flop

Meistgelesene Nachrichten